natgillin/translations-raw huggingface dataset:
Sulfonylurinstoffer regulerer insulinsekretionen ved at lukke den ATP-følsomme kaliumkanal i - cellemembranen.
Sulphonylureas regulate insulin secretion by closing the ATP-dependent potassium channels in the beta cell membrane.
Sulfonylurinstoffer såsom glipizid (anvendt til behandling af højt blodsukker)
Sulfonylureas such as glipizide (used to treat high blood sugar).
Sulfonylurinsyre (bruges til at behandle sukkersyge),
ulfonylurea (used to treat diabetes),
Sulphamethoxazol/trimethoprim
Sulphamethoxazole/
Sulphamethoxazol/trimethoprim-
Sulphamethoxazole/trimethoprim
sult
hunger
Sult, pyreksi
Hunger, Pyrexia
sultfornemmelse, hovedpine, synsforstyrrelser humørsvingninger eller forvirring.
feeling hungry, headache, change in vision a change in your mood or feeling confused.
sultfornemmelse, vægttab eller vægtstigning
feeling hungry, weight loss or weight gain
Sultoprid
Tacrolimus
Sultroprid (et lægemiddel til behandling af visse adfærdsforstyrrelser hos voksne)
Sultropride (a medicine prescribed to treat certain behavioural disorders in adults),
Sum af tylvalosin og 3-O- acetyltylosin
Sum of tylvalosin and 3-O- acetyltylos in
Sumatriptan og lignende lægemidler, hvor navnet på det aktive stof ender på “triptan”.
umatriptan and similar medicines with active substance names ending in “triptans”
Sumatriptan og lignende lægemidler, hvor navnet på det aktive stof ender på “triptan”.
umatriptan and similar medicines with active substance names ending in “triptans”.
Summen af alle restkoncentr ationer med betalactamst ruktur udtrykt som desfuroylcef tiofur
Sum of all residues retaining the betalactam structure expressed as desfuroyl- ceftiofur
Summen af ekstraherbare rester, som kan oxideres til oxfendazol- sulfon
Sum of extractable residues which may be oxidised to oxfenda- zole sulphone
Summende, hvislende, fløjtende, ringende eller anden vedvarende støj i ørerne
buzzing, hissing, whistling, ringing or other persistent noise in the ears
Sundhedseksperter anbefaler, at HIV- smittede kvinder ikke ammer deres spædbørn under nogen omstændigheder for at undgå overførsel af HIV.
Health experts recommend that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.
Sundhedseksperter er bekymrede for, at en kommende influenzapandemi kan forårsages af H5N1- stammen af virusset.
Health experts are concerned that a future flu pandemic could be caused by the H5N1 strain of the virus.
Sundhedsinstitutionens standard sterilprocedurer for forberedelse af huden skal overholdes for at undgå mikrobiel forurening og infektion.
Aseptic skin preparation should be performed according to the healthcare institution’s standard sterile operating procedures to avoid microbial contamination and infection.
Sundhedsinstitutionens standard sterilprocedurer for forberedelse af huden skal overholdes for at undgå mikrobiel forurening og infektion.
The healthcare institution’s standard sterile operating procedures for skin preparation must be followed to avoid microbial contamination and infection.
Sundhedsinstitutionens standard sterilprocedurer for forberedelse af huden skal overholdes for at undgå mikrobiel forurening og infektion.
To avoid microbial contamination and infection, aseptic skin preparation should be performed according to the healthcare institution’s standard sterile operating procedures.
Sundhedspersonale bedes indberette alle formodede bivirkninger via det nationale indberetningssystem, der er anført i Bilag V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Sundhedspersonale bliver bedt om at indberette eventuelle formodede bivirkninger via det nationale rapporteringssystem til Sundhedsstyrelsen
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Sundhedspersonale og assisterende personale skal være instrueret i sikker og korrekt opbevaring, håndtering og administration af IMLYGIC og i den kliniske opfølgning på patienter, der er behandlet med IMLYGIC;
Trained HCPs and support personnel regarding safe and appropriate storage, handling, and administration of IMLYGIC, and clinical follow-up for patients treated with IMLYGIC;
Sundhedspersonale skal være meget forsigtige når de håndterer brugte nåle – for at reducere risikoen for stikuheld og krydsinfektion.
Caregivers must be very careful when handling used needles – to reduce the risk of needle sticks and cross-infection.
Sundhedspersonale skal være opmærksomme på, at Norvir oral opløsning er meget koncentreret og indeholder hjælpestofferne ethanol (43,2% v/v) og propylenglycol (26,0% v/v).
Healthcare professionals should be aware that Norvir oral solution is highly concentrated and contains the excipients alcohol (43.2% v/v) and propylene glycol (26.0% v/v).
Sundhedspersonale, familie og andre hjælpere skal følge generelle forsigtighedsregler, når de fjerner og kasserer nåle, for at nedsætte risikoen for stikuheld.
Healthcare professionals, relatives and other carers should follow general precautionary measures for removal and disposal of needles to eliminate the risk of unintended needle sticks.
Sundhedspersonales utilsigtede eksponering for IMLYGIC
Accidental exposure of Healthcare Professionals (HCPs) to IMLYGIC
Sundhedspersonalet klargør en opløsning af antithrombin alfa, der skal indgives ved infusion direkte i en vene.
Your health care provider will prepare a solution of antithrombin alfa to be administered to you through your vein.
Sundhedspersonalet rådes til ikke at smide ubrugt Zoledronsyre Teva i kloakken.
Healthcare professionals are advised not to dispose of unused Zoledronic acid Teva via the domestic sewage system.
Sundhedspersonalet skal også modtage en brochure og et huskekort, som skal udleveres til personer, der tager Truvada som profylakse før eksponering.
Healthcare professionals will also receive a brochure and reminder card to hand out to individuals receiving Truvada for pre-exposure prophylaxis.
Sundhedspersonalet skal vurdere fordele og potentielle risici ved administration af Pandemisk influenzavaccine H5N1 MedImmune til disse personer.
Healthcare providers need to assess the benefits and potential risks of administering Pandemic influenza vaccine H5N1 MedImmune to these individuals.
Sundhedspersonalet skal vurdere fordele og potentielle risici ved at administrere Pandemisk influenzavaccine H5N1 MedImmune til gravide kvinder.
Healthcare providers need to assess the benefit and potential risks of administering Pandemic influenza vaccine H5N1 MedImmune to pregnant women.
Sundhedspersonalet skal være instrueret i registrering af batchnumre i patientens journal og på patientkortet, gældende for alle injektioner, og i oplysning af batchnummeret i forbindelse med indberetning af lægemiddelbivirkninger.
Trained HCPs to record batch number information in patient´s charts and on the patient´s alert card for all injections and to provide the batch number when reporting adverse drug reactions.
Sundhedspersonalet skal være opmærksom på, at anvendelse af Vibativ kan interferere med visse koagulations-laboratorieprøver og kvalitative og kvantitative urinproteinprøver.
Healthcare professionals should be aware that the administration of Vibativ may interfere with some coagulation laboratory tests and qualitative and quantitative urine protein tests.
Sundhedspersonalet skal være tilstrækkeligt uddannet og erfarent for at minimere risikoen for forekomst af de anførte lægemiddelbivirkninger hos patienterne, sundhedspersonalet og patienternes nære kontakter;
Adequately trained and experienced HCPs in order to minimise the risk of occurrence of specified adverse drug reactions in patients, HCPs, and close contacts of the patients;
Sundhedspersonalet vil altid notere præcist det lægemiddel, du bruger, i din journal.
Your healthcare professional will always record the exact product you are using.
Sundhedspersonalet vil fortælle dig, hvor mange fyldte injektionssprøjter med Repatha, der skal bruges til din dosis.
Your healthcare provider will tell you how many Repatha pre-filled syringes are needed for your dose.
Sundhedspersonalet vil fortælle dig, hvor mange fyldte pen med Repatha, der skal bruges til din dosis.
Your healthcare provider will tell you how many Repatha pre-filled pens are needed for your dose.
Sundhedspersonalet vil tage dette i betragtning, før du bliver behandlet med Praxbind.
They will take this into account before treating you with Praxbind.
Sundhedspersonalet vil undgå potentielle komplikationer ved at sikre, at:
Your healthcare professional will avoid potential complications by ensuring:
Sundhedspersonalet vil vise dig, hvordan du sætter dine forbindinger på.
Apply the dressing as instructed by your healthcare professional.
Sundhedspersonalets forpligtelser i forbindelse med ordinationen af Revlimid
Obligations of the health care professional in relation to the prescribing of Revlimid
Sundhedspersonalets forpligtelser i forbindelse med ordinering af pomalidomid
Obligations of the health care professional in relation to the prescribing of pomalidomide
Sundhedspersonalets pligter ved ordination eller salg af Thalidomide Celgene, herunder
Obligations of healthcare professionals who intend to prescribe or dispense Thalidomide Celgene including
Sundhedspersonalets uddannelsesmateriale skal indeholde følgende hovedelementer:
The healthcare professional’s educational material should contain the following key elements:
Sundhedspersoner opfordres til at indberette alle formodede bivirkninger direkte via det nationale rapporteringssystem anført i Appendiks V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Sundhedspersoner opfordres til at indberette alle formodede bivirkninger via det nationale rapporteringssystem anført i Appendiks V.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V
Sundhedspersoner skal kende de bivirkninger, der kan forekomme under eller kort efter behandling, og de skal vide, hvordan disse behandles.
Healthcare professionals should be aware of side effects that may arise during or shortly after treatment, and how to treat them.
Sundhedsrelateret livskvalitet, bedømt ved St George's Respiratory Questionnaire (SGRQ), blev forbedret ved alle aktive behandlinger sammenlignet med placebo.
Health Related Quality of Life, as measured by the St George’s Respiratory Questionnaire (SGRQ) was improved by all active treatments in comparison with placebo.
Sunitinib bør anvendes med forsigtighed hos patienter med kendt forlængelse af QT-intervallet i anamnesen, patienter der tager antiarytmika eller lægemidler der kan forlænge QT-intervallet, eller patienter med relevant præeksisterende hjertesygdom, bradykardi eller elektrolytforstyrrelser.
Sunitinib should be used with caution in patients with a known history of QT interval prolongation, patients who are taking antiarrhythmics, or medicinal products that can prolong QT interval, or patients with relevant pre-existing cardiac disease, bradycardia, or electrolyte disturbances.
Sunitinib er identificeret som en hæmmer af receptorerne for trombocytafledte vækstfaktorer (PDGFR og PDGF), vaskulære endotel- vækstfaktorer (VEGFR1, VEGFR2 og VEGF3), stamcellefaktor (KIT), Fms-lignende tyrosinkinase-3 (FLT3), kolonistimulerende faktor (CSF-1R) og gliacelleafledt neurotrof faktor (RET).
Sunitinib was identified as an inhibitor of platelet-derived growth factor receptors (PDGFRα and PDGFRβ), vascular endothelial growth factor receptors (VEGFR1, VEGFR2 and VEGFR3), stem cell factor receptor (KIT), Fms-like tyrosine kinase-3 (FLT3), colony stimulating factor receptor (CSF-1R), and the glial cell-line derived neurotrophic factor receptor (RET).
Sunitinib har vist forlængelse af QTcF-interval (Fredericas korrektion) ved ca. dobbelt terapeutisk koncentration.
At approximately twice therapeutic concentrations, sunitinib has been shown to prolong the QTcF Interval (Frederica’s Correction).
Sunitinib hæmmer gentagne receptortyrosinkinaser (RTK), som indgår i tumorvækst, neoangiogenese og metastaserende progression af cancer.
Sunitinib inhibits multiple receptor tyrosine kinases (RTKs) that are implicated in tumour growth, neoangiogenesis, and metastatic progression of cancer.
Sunitinib metaboliseres hovedsageligt af CYP3A4, det cytochrom P450-isoform, som producerer dets aktive hovedmetabolit, desethylsunitinib, og som derefter metaboliseres yderligere af det samme isoenzym.
Sunitinib is metabolised primarily by CYP3A4, the cytochrome P450 isoform which produces its primary active metabolite, desethyl sunitinib, which is then further metabolized by the same isoenzyme.
Sunitinib og dets hovedmetabolit er de vigtigste forbindelser identificeret i plasma, urin og fæces med henholdsvis 91,5%, 86,4% og 73,8% af radioaktivitet i poolede prøver.
Sunitinib and its primary active metabolite were the major compounds identified in plasma, urine and faeces, representing 91.5%, 86.4% and 73.8% of radioactivity in pooled samples, respectively.
Sunitinib og dets primære metabolit metaboliseres hovedsageligt i leveren.
Sunitinib and its primary metabolite are mainly metabolized by the liver.
Sunitinib skal bruges med forsigtighed hos patienter med risiko for disse hændelser, eller med disse hændelser i anamnesen.
Use sunitinib with caution in patients who are at risk for, or who have a history of, these events.
Sunitinib:
Sunitinib
Sunitinib: til behandling af kræft
Sunitinib: to treat cancer
Sunkutan
subcutaneous
Sunovion-logo
Sunovion logo
Sunset y ellow FCF (E 110) er et farvestof, som kan give allergiske reaktioner.
Sunset Yellow FCF (E110) colouring agent may cause allergic reactions.
Sunset yellow (E110) aluminiumpigment.
Sunset yellow (E110) aluminium lake.
Sunset yellow (E110) er et farvestof, som kan forårsage allergiske reaktioner.
Sunset Yellow (E110) is a colouring agent which may cause allergic reactions.
Sunset Yellow (E110) som farve
Sunset Yellow (E110) as a colorant
Sunset yellow FCF (E 110) er et farvestof, som kan give allergiske reaktioner.
Sunset Yellow FCF (E110) colouring agent may cause allergic reactions.
Sunset yellow FCF (E 110) Quinolingul Aluminium Lake (E104)
Indigo carmine aluminum lake (E132) Sunset yellow FCF aluminum lake (E110) Quinoline yellow aluminium lake (E104).
Sunset yellow FCF (E 110) Rød jernoxid (E 172)
Sunset yellow FCF aluminium lake (E110) Iron oxide red (E172)
Sunset yellow FCF (E 110) Rød jernoxid (E 172) Macrogol /PEG 4000
Indigo carmine aluminum lake (E132) Sunset yellow FCF aluminum lake (E110) Iron oxide red (E172)
Sunset Yellow FCF (E110)
Sunset yellow FCF Aluminium Lake (E110)
Sunset yellow FCF (E110) (se afsnit 2)
Sunset Yellow FCF (E110) (see section 2)
Sunset Yellow FCF (E110) Allura Red AC (E129) Indigokarmin
Sunset Yellow FCF (E110) Allura Red AC (E129) Indigo Carmine
Sunset yellow FCF (E110).
Sunset yellow FCF (E110)
Sunset yellow FCF aluminiumpigment (E110) Macrogol 3350 (E1521)
Sunset yellow FCF aluminium lake (E110) Macrogol 3350 (E1521)
Sunset yellow FCF aluminiumpigment (E110), macrogol 3350 (E1521), polyvinylalkohol (delvist hydrolyseret) (E1203), talkum (E553B), titandioxid (E171), gul jernoxid (E172).
Sunset yellow FCF aluminium lake (E110), macrogol 3350 (E1521), polyvinyl alcohol (partially hydrolysed) (E1203), talc (E553B), titanium dioxide (E171), iron oxide yellow (E172).
Suomi/Finland
Eesti
Suomi/Finland
Portugal
Suomi/Finland
Slovenija
Suomi/Finland rationpharm Oy
Suomi/Finland ratiopharm Oy
Superficiel tromboflebitis
Thrombophlebitis superficial
Superficielle svampeinfektioner, specielt oral og vaginal candidiasis, opstod oftere hos LEMTRADA- behandlede patienter (12 %) end hos IFNB-1a-patienter (3 %) i kontrollerede, kliniske MS-forsøg.
Superficial fungal infections, especially oral and vaginal candidiasis, occurred more commonly in LEMTRADA -treated patients (12%) than in patients treated with IFNB-1a (3%) in controlled clinical trials in MS.
Superficielt ødem
Superficial oedema
Superficielt ødem Pleuraeffusion Generaliseret ødem Perikardie-effusion Pulmonal hypertension
Superficial oedema Pleural effusion Generalised oedema Pericardial effusion Pulmonary hypertension
Superinfektioner
Superinfections
Superiori- tet p- værdi
Superiority p-value
Superiori- tet p-værdi
Superiority p-value
Superiorite t p-værdi
Superiority p- value
Superioritet (statistisk signifikans) i forhold til placebo for familie og skole samt indlæringsdomæner for WFIRS-P-score var ikke konsekvent klarlagt i dette studie.
Superiority (statistical significance) over placebo on the family and school, and learning domains of the WFIRS-P score was not consistently established in this study.
Superioritet p-værdi
Superio rity p- value
Superioritet p-værdi
Superiority p- value
Supplement til metformin alene eller i kombination med pioglitazon
Add-on to metformin alone or in combination with pioglitazone
Supplement til metformin og en sulfonylurinstofbehandling
Add-on to metformin and a sulphonylurea therapy
Supplement til metforminbehandling
Add-on to metformin therapy
Supplement til orale antidiabetika
Add-on to oral glucose lowering medicinal products
Supplement til pioglitazon +/- metforminbehandling
Add-on to pioglitazone +/- metformin therapy
Supplement til sulfonylurinstof alene eller i kombination med metformin
Add-on to sulphonylurea alone or in combination with metformin
Supplerende
Adjunctive
Supplerende behandling
Adjunctive therapy
Supplerende behandling til RTen i form af konkomitant behandling med TMZ, efterfulgt af monoterapi med TMZ, til patienter med nydiagnosticeret glioblastoma multiforme medførte en statistisk signifikant forbedret samlet overlevelse, sammenlignet med RT alene (figur 1).
The addition of concomitant TMZ to RT, followed by TMZ monotherapy in the treatment of patients with newly diagnosed glioblastoma multiforme demonstrated a statistically significant improvement in overall survival (OS) compared with RT alone (Figure 1).
Supplerende data fra støttende undersøgelse viste en tilsvarende effekt af Ravicti hos børn over 2 måneder.
Additional data from supportive studies showed a similar effect of Ravicti in children from 2 months of age.
Supplerende dosis efter hæmodialyse (mg)
Supplementary dosage fo
Supplerende dosis efter hæmodialyse (mg)
Supplementary dose following haemodialysis (mg)
Supplerende information vedr. specielle populationer
Additional information on special populations
Supplerende jernbehandling anbefales til alle patienter med serumferritinværdier under
Supplementary iron therapy is recommended for all patients with serum ferritin values below
Supplerende jerntilskud anbefales til alle patienter med serum ferritin-værdier på under 100 g/l eller til de patienter, hvis transferrinmætning er under 20%.
Supplementary iron therapy is recommended for all patients with serum ferritin values below 100 µg/l or whose transferrin saturation is below 20%.
Supplerende jerntilskud anbefales til alle patienter med serum-ferritin under 100 µg/l eller med transferrinmætning under 20 %.
Supplementary iron therapy is recommended for all patients with serum ferritin values below 100 µg/l or whose transferrin saturation is below 20%.
Supplerende monitorering specifikt for børn og unge
Supplemental monitoring specific for children and adolescents
Supplerende prævention er ikke nødvendig.
No back-up contraception is needed.
Supplerende Soliris-dosis ved hver enkelt plasmaintervention
Supplemental Soliris Dose With Each Plasma Intervention
Supplerende thyreoideamonitorering specifikt for børn og unge
Thyroid supplemental monitoring specific for children and adolescents
Supplerende thyroideamonitorering specifikt for børn og unge
Thyroid supplemental monitoring specific for children and adolescents
Supportive foranstaltninger samt administration af specifik behandling for Clostridium difficile skal overvejes under disse omstændigheder.
In such a circumstance, the use of supportive measures together with the administration of specific treatment for Clostridium difficile should be considered.
suppression er påkrævet.
is warranted.
Supprimeringen af CYP450-ekspressionen kan derfor reverseres ved påbegyndelse af potent cytokinhæmmende behandling, som fx tocilizumab.
Thus, CYP450 expression may be reversed when potent cytokine inhibitory therapy, such as tocilizumab, is introduced.
Supraventrikul ær takykardi
Supraventricular tachycardia
Supraventrikulær takykardi
Palpitation Tachycardia
Supraventrikulær takykardi, ekstrasystole
Supraventricular tachycardia, extrasystole
Supraventrikulære ekstrasystoler Takykardi
Supraventricular tachycardia Supraventricular extrasystoles Tachycardia
Suprelorin 4,7 mg implantat til hunde
Suprelorin 4.7 mg implant for dogs
Suprelorin 9,4 mg implantat til hunde og ildere
Suprelorin 9.4 mg implant for dogs and ferrets
Suprelorin 9,4 mg implantat til hunde og ildere
Suprelorin 9.4 mg implant for dogs and ferrets.
Suprelorin er et hvidt til bleggult cylindrisk implantat indeholdende 4,7 mg deslorelin (som deslorelinacetat).
Suprelorin is a white to pale yellow cylindrical implant containing 4.7 mg deslorelin (as deslorelin acetate).
Suprelorin er et hvidt til bleggult cylindrisk implantat indeholdende 9,4 mg deslorelin (som deslorelinacetat).
Suprelorin is a white to pale yellow cylindrical implant containing 9.4 mg deslorelin (as deslorelin acetate).
Sure opstød
Acid reflux
Sure opstød, mavekatar, mavesmerter, diaré, opkastning, kvalme, tør mund
Acid reflux, gastritis, abdominal pain, diarrhoea, vomiting; feeling sick (nausea), dry mouth
Sure opstød/halsbrand.
Upset stomach (dyspepsia).
SureClick fyldte penne.
SureClick pre-filled pens.
Surrey GU16 7SR
Camberley
Surrey GU16 7SR Storbritannien
Surrey GU16 7SR United Kingdom
Surrey GU16 7SR Storbritannien
Surrey GU16 7SR United Kingdom.
Surrey GU16 7SR Storbritannien
Surrey, GU16 7SR United Kingdom
Surrey GU16 7SR Storbritannien
Surrey, GU16 7SR United Kingdom.
Surrey GU16 7SR Storbritannien.
Surrey, GU16 7SR United Kingdom.
Surrey GU16 7SR United Kingdom.
B-2870 Puurs,
Surrey GU16 7SR United Kingdom.
Surrey, GU16 7SR United Kingdom.
Surrey KT16 0RS Storbritannien
Surrey KT16 0RS United Kingdom
Surrey KT22 9AD Storbritannien
Surrey KT22 9AD United Kingdom
Surrey, GU 16 7SR United Kingdom
Surrey, GU16 7SR United Kingdom
Surrey, GU16 7SR Storbritannien
Surrey, GU16 7SR United Kingdom
Surrey, GU16 7SR Storbritannien.
Surrey, GU16 7SR United Kingdom.
Survival Probability
Other (N=252)
Survival Time (months)
Superiorityp-value
Susen for ørerne og døvhed er mulige bivirkninger.
Ringing in the ears and deafness are possible side effects.
suspension
injection
suspension
Suspension for
Suspension
{NATURE/TYPE}
suspension (H1N1): hætteglas (glas)
Suspension (H1N1): vial (glass);
SUSPENSION HÆTTEGLAS
SUSPENSION VIAL
Suspension i hætteglas: Polysorbat 80
Suspension vial: Polysorbate 80
suspension Injektionsvæske,
Suspension for
Suspension og
Suspension and
Suspension og brusegranulat til oral suspension.
Suspension and effervescent granules for oral suspension.
Suspension og emulsion skal sammenblandes før administration
Suspension and emulsion to be mixed before administration
Suspension og emulsion til injektionsvæske, emulsion 10 hætteglas med suspension (antigen)
Suspension and emulsion for emulsion for injection 10 vials of suspension (antigen)
Suspension og emulsion til injektionsvæske, emulsion.
Emulsion for emulsion for injection
Suspension og solvens til oral spray
Suspension and solvent for oral spray
Suspension og solvens til suspension til injektion
Suspension and diluent for suspension for injection
Suspension og solvens, til suspension til injektion.
Suspension and diluent for suspension for injection.
Suspension og solvent til suspension til injektion
Suspension and solvent for suspension for injection
Suspension til
Suspension
Suspension til Adjupanrix injektionsvæske, emulsion
Suspension for emulsion for injection for Adjupanrix
Suspension til Arepanrix injektionsvæske, emulsion
Suspension for emulsion for injection for Arepanrix
Suspension til brug i drikkevand
Suspension for use in drinking water